Research location
Erlangen
Bavaria, Germany
Advertisement
Research activity in Erlangen
Bavaria, GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 108 trials and 108 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Erlangen
108 linked trials · page 2 of 3Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)NCT03725059 · 2018-12-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)NCT03765918 · 2018-12-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Effect of Baricitinib Treatment on Peripheral Bone in RANCT03701789 · 2018-09-11 · 1 site observation
UNKNOWN
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]NCT03529110 · 2018-08-09 · 1 site observation
COMPLETED
Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBCNCT03289819 · 2018-03-23 · 1 site observation
COMPLETED
Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast CancerNCT03241810 · 2017-08-15 · 1 site observation
TERMINATED
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast CancerNCT03155997 · 2017-07-12 · 1 site observation
ACTIVE_NOT_RECRUITING
A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT03034915 · 2017-06-16 · 1 site observation
COMPLETED
Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial CarcinomaNCT03274349 · 2017-03-17 · 1 site observation
UNKNOWN
Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate CancerNCT02799602 · 2016-11-30 · 1 site observation
COMPLETED
Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYSTNCT02657356 · 2016-10-04 · 1 site observation
TERMINATED
Charité HT-ProstateNCT04159051 · 2016-10-01 · 1 site observation
UNKNOWN
Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination DeficiencyNCT02789332 · 2016-09-01 · 1 site observation
COMPLETED
Effect of Whole Body Electromyostimulation and/or Protein Supplementation on Sarcopenic Obesity in 70+NCT02857660 · 2016-08-01 · 1 site observation
COMPLETED
Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 DiabetesNCT02752113 · 2016-04-01 · 1 site observation
COMPLETED
Pertuzumab in First Line Treatment of HER2-positive Metastatic Breast Cancer PatientsNCT02642458 · 2016-03-01 · 1 site observation
UNKNOWN
The Influence of Aircraft Noise Exposure on Renal Hemodynamic in Healthy IndividualsNCT02783456 · 2016-03-01 · 1 site observation
COMPLETED
Therapy Management With Nab-Paclitaxel in Daily RoutineNCT02642406 · 2015-12-01 · 1 site observation
UNKNOWN
Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast CancerNCT02492711 · 2015-08-24 · 1 site observation
COMPLETED
Adjunct Minocyline in Treatment-resistant DepressionNCT02456948 · 2015-01-01 · 1 site observation
COMPLETED
Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium FunctionNCT02471963 · 2014-12-01 · 1 site observation
COMPLETED
Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled TrialNCT01962571 · 2014-11-25 · 1 site observation
COMPLETED
A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)NCT02034916 · 2013-12-13 · 1 site observation
TERMINATED
Dimethyl Fumarate (DMF) Observational StudyNCT02047097 · 2013-11-19 · 1 site observation
COMPLETED
Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019NCT01797965 · 2013-02-15 · 1 site observation
TERMINATED
Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesNCT01618370 · 2012-07-22 · 1 site observation
COMPLETED
Evaluation of Specific Biomarkers in Primary Invasive Breast CancerNCT01476111 · 2011-12-01 · 1 site observation
TERMINATED
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast CancerNCT01220128 · 2011-04-11 · 1 site observation
TERMINATED
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary DiseaseNCT01316900 · 2011-03-01 · 1 site observation
COMPLETED
Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast CancerNCT01234337 · 2011-02-21 · 1 site observation
COMPLETED
Efficacy and Safety of Ambrisentan in Children 8-18yrsNCT01332331 · 2011-01-04 · 1 site observation
TERMINATED
Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected PersonsNCT01218113 · 2010-11-08 · 1 site observation
COMPLETED
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)NCT01104584 · 2010-05-01 · 1 site observation
COMPLETED
Long-term Follow-up of Participants From Studies Evaluating GSK HIV VaccineNCT01092611 · 2010-03-22 · 1 site observation
COMPLETED
Sympathetic Nerve Activity in Renal FailureNCT00892892 · 2009-11-01 · 1 site observation
WITHDRAWN
A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01053988 · 2009-10-05 · 1 site observation
COMPLETED
Contrast Sensitivity in GlaucomaNCT00947869 · 2009-04-01 · 1 site observation
UNKNOWN
Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years OldNCT00814762 · 2009-02-03 · 1 site observation
COMPLETED
Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace)NCT01908556 · 2009-02-01 · 1 site observation
UNKNOWN
Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung CancerNCT00707304 · 2008-11-01 · 1 site observation
COMPLETED
Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy VolunteersNCT00750282 · 2008-08-01 · 1 site observation
COMPLETED
ZK 230211 in Postmenopausal Woman With Metastatic Breast CancerNCT00555919 · 2008-03-01 · 1 site observation
COMPLETED
Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist TherapyNCT00603525 · 2008-01-01 · 1 site observation
TERMINATED
A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive PatientsNCT00627952 · 2007-11-01 · 1 site observation
COMPLETED
Sympathetic Overactivity in Essential HypertensionNCT00541619 · 2007-10-01 · 1 site observation
WITHDRAWN
Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast CancerNCT00374322 · 2006-08-01 · 1 site observation
COMPLETED
Results Of Patient Rated Asthma Control Test In Comparison To Diary Card DataNCT00363480 · 2006-05-17 · 1 site observation
COMPLETED
Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir HypersensitivityNCT00340080 · 2006-04-01 · 1 site observation
COMPLETED
Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive TherapyNCT00150839 · 2006-03-01 · 1 site observation
COMPLETED
Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)NCT00256919 · 2005-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.